XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Capital Stock and Equity Transactions (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Oct. 13, 2021
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2020
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Common stock, shares authorized (in shares)   700,000,000 700,000,000   700,000,000 700,000,000  
Common stock, par value (in dollars per share)   $ 0.001     $ 0.001 $ 0.001  
Preferred stock, shares authorized (in shares)   10,000,000          
Derivative liability $ 4,392,870            
Increase in common shares $ 150,000,000     $ 838,303      
Preferred stock, par value (in dollars per share)   $ 0.001       $ 0.001  
Common stock on a fully diluted basis   $ 95,428       $ 93,315  
Common stock shares issued   95,428,575       93,316,288  
Vendor [Member]              
Fair market value of shares issued and expensed   $ 30,420 $ 63,854        
Issuance of common stock to vendors   640,000 927,517        
Employees [Member]              
Common stock shares issued   1,472,287 1,705,282        
Fair market value   $ 72,362 $ 135,400        
Preferred Stock Series A [Member]              
Preferred stock, shares authorized (in shares)   10,000,000       10,000,000  
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001       $ 0.001  
Aggeregate shares of common stock 324,325            
Common stock on a fully diluted basis             $ 3,714,877
Series B Preferred Stock [Member]              
Aggeregate shares of common stock   7,567          
Common stock shares issued upon conversion of preferred stock   1,120,064